Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2070]

Editor’s Choice for September 2018

Prof Gordon McVie - Founding Editor, ecancer

Editor’s Choice for September 2018 ( Prof Gordon McVie - Founding Editor, ecancer )

The microbiome – a novel paradigm in oncology research

Dr Alasdair Scott - Imperial College London, London, UK

The microbiome – a novel paradigm in oncology research ( Dr Alasdair Scott - Imperial College London, London, UK )

Editor's Choice for August 2018

Prof Gordon McVie - Founding Editor, ecancer

Editor's Choice for August 2018 ( Prof Gordon McVie - Founding Editor, ecancer )

Updates from a range of lung cancer studies

Prof Edgardo S. Santos - Lynn Cancer Institute, Boca Raton, USA

Updates from a range of lung cancer studies ( Prof Edgardo S. Santos - Lynn Cancer Institute, Boca Raton, USA )

Large B-cell lymphoma: ZUMA-1 trial

Dr Frederick Locke - Moffitt Cancer Center, Tampa, USA

Large B-cell lymphoma: ZUMA-1 trial ( Dr Frederick Locke - Moffitt Cancer Center, Tampa, USA )

Five practice changing shifts in oncology

Dr Jack West - Swedish Cancer Institute, Seattle, USA

Five practice changing shifts in oncology ( Dr Jack West - Swedish Cancer Institute, Seattle, USA )

Updates on data and results from PROPHECY, PALOMA-3 and CHECKMATE-227

Ignacio Gil-Bazo - Clínica Universidad de Navarra, Pamplona, Spain

Updates on data and results from PROPHECY, PALOMA-3 and CHECKMATE-227 ( Ignacio Gil-Bazo - Clínica Universidad de Navarra, Pamplona, Spain )

Rare mutations in non small cell lung cancer

Dr Tom Stinchcombe - Duke Cancer Institute, Durham, USA

Rare mutations in non small cell lung cancer ( Dr Tom Stinchcombe - Duke Cancer Institute, Durham, USA )

Several important studies for lung cancer

Prof Luis Raez - Herbert Wertheim College of Medicine, Miami, USA

Several important studies for lung cancer ( Prof Luis Raez - Herbert Wertheim College of Medicine, Miami, USA )

Four studies about relapsed myeloma and advanced disease

Prof Melissa Alsina -Moffitt Cancer Center, Tampa, USA

Four studies about relapsed myeloma and advanced disease ( Prof Melissa Alsina -Moffitt Cancer Center, Tampa, USA )

The role of observational epidemiology in cancer research

Prof David Hunter - University of Oxford, Oxford, UK

The role of observational epidemiology in cancer research ( Prof David Hunter - University of Oxford, Oxford, UK )

The ICMC: a new path for microbiome research

Prof Julian Marchesi - Imperial College London, London, UK

The ICMC: a new path for microbiome research ( Prof Julian Marchesi - Imperial College London, London, UK )

More from ecancer